Skip to main content
Top
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Research article

Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006

Authors: Jonathan E Moore, Michelle E Kruijshaar, L Peter Ormerod, Francis Drobniewski, Ibrahim Abubakar

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

Non-tuberculous mycobacteria have long been identified as capable of causing human disease and the number at risk, due to immune-suppression, is rising. Several reports have suggested incidence to be increasing, yet routine surveillance-based evidence is lacking. We investigated recent trends in, and the epidemiology of, non-tuberculous mycobacterial infections in England, Wales and Northern Ireland, 1995-2006.

Methods

Hospital laboratories voluntarily report non-tuberculous mycobacterial infections to the Health Protection Agency Centre for Infections. Details reported include age and sex of the patient, species, specimen type and source laboratory. All reports were analysed.

Results

The rate of non-tuberculous mycobacteria reports rose from 0.9 per 100,000 population in 1995 to 2.9 per 100,000 in 2006 (1608 reports). Increases were mainly in pulmonary specimens and people aged 60+ years. The most commonly reported species was Mycobacterium avium-intracellulare (43%); M. malmoense and M. kansasii were also commonly reported. M. gordonae showed the biggest increase over the study period rising from one report in 1995 to 153 in 2006. Clinical information was rarely reported.

Conclusions

The number and rate of reports increased considerably between 1995 and 2006, primarily in older age groups and pulmonary specimens. Increases in some species are likely to be artefacts but real changes in more pathogenic species, some of which will require clinical care, should not be excluded. Enhanced surveillance is needed to understand the true epidemiology of these infections and their impact on human health.
Appendix
Available only for authorised users
Literature
1.
go back to reference Timpe A, Runyon EH: The relationship of atypical acid-fast bacteria to human disease; a preliminary report. J Lab Clin Med. 1954, 44: 202-209.PubMed Timpe A, Runyon EH: The relationship of atypical acid-fast bacteria to human disease; a preliminary report. J Lab Clin Med. 1954, 44: 202-209.PubMed
3.
go back to reference Raviglione M: Diseases due to other mycobacteria. Control of Communicable Diseases Manual. Edited by: David L, Heymann M. 2004, Washington: American Public Health Association, 572-573. 18 Raviglione M: Diseases due to other mycobacteria. Control of Communicable Diseases Manual. Edited by: David L, Heymann M. 2004, Washington: American Public Health Association, 572-573. 18
4.
go back to reference Banks J, Jenkins PA: Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Thorax. 1987, 42: 838-842. 10.1136/thx.42.11.838.CrossRefPubMedPubMedCentral Banks J, Jenkins PA: Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Thorax. 1987, 42: 838-842. 10.1136/thx.42.11.838.CrossRefPubMedPubMedCentral
5.
go back to reference Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax. 2000, 55: 210-218. 10.1136/thorax.55.3.210. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax. 2000, 55: 210-218. 10.1136/thorax.55.3.210.
6.
go back to reference Horsburgh CR, Selik RM: The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis. 1989, 139: 4-7.CrossRefPubMed Horsburgh CR, Selik RM: The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis. 1989, 139: 4-7.CrossRefPubMed
8.
go back to reference Herbert J, Watson JM: Mycobacterial infections - guidelines for reporters. Communicable Disease Report. 11 (1): 1-2. 4-1-2001 Herbert J, Watson JM: Mycobacterial infections - guidelines for reporters. Communicable Disease Report. 11 (1): 1-2. 4-1-2001
9.
go back to reference Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audigier C, Offredo C, Guillemot D, Halley S, Akoua-Koffi C, Vincent V, Sivadon-Tardy V, Ferroni A, Berche P, Scheinmann P, Lenoir G, Gaillard JL: Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis. 2003, 9: 1587-1591.CrossRefPubMedPubMedCentral Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audigier C, Offredo C, Guillemot D, Halley S, Akoua-Koffi C, Vincent V, Sivadon-Tardy V, Ferroni A, Berche P, Scheinmann P, Lenoir G, Gaillard JL: Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis. 2003, 9: 1587-1591.CrossRefPubMedPubMedCentral
10.
go back to reference Resch B, Eber E, Beitzke A, Bauer C, Zach M: Pulmonary infection due to Mycobacterium gordonae in an adolescent immunocompetent patient. Respiration. 1997, 64: 300-303. 10.1159/000196691.CrossRefPubMed Resch B, Eber E, Beitzke A, Bauer C, Zach M: Pulmonary infection due to Mycobacterium gordonae in an adolescent immunocompetent patient. Respiration. 1997, 64: 300-303. 10.1159/000196691.CrossRefPubMed
11.
go back to reference Lamden K, Watson JM, Knerer G, Ryan MJ, Jenkins PA: Opportunist mycobacteria in England and Wales: 1982 to 1994. CDR. 1996, 6: R147-R151. Lamden K, Watson JM, Knerer G, Ryan MJ, Jenkins PA: Opportunist mycobacteria in England and Wales: 1982 to 1994. CDR. 1996, 6: R147-R151.
12.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K, ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America: An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med. 2007, 175: 367-416. 10.1164/rccm.200604-571ST.CrossRefPubMed Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K, ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America: An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med. 2007, 175: 367-416. 10.1164/rccm.200604-571ST.CrossRefPubMed
13.
go back to reference van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D: Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax. 2009, 64: 502-506. 10.1136/thx.2008.110957.CrossRefPubMed van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D: Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax. 2009, 64: 502-506. 10.1136/thx.2008.110957.CrossRefPubMed
14.
go back to reference Marras TK, Chedore P, Ying AM, Jamieson F: Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax. 2007, 62: 661-666. 10.1136/thx.2006.070797.CrossRefPubMedPubMedCentral Marras TK, Chedore P, Ying AM, Jamieson F: Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax. 2007, 62: 661-666. 10.1136/thx.2006.070797.CrossRefPubMedPubMedCentral
15.
go back to reference National Collaborating Centre for Chronic Conditions: Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2006, London: Royal College of Physicians National Collaborating Centre for Chronic Conditions: Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2006, London: Royal College of Physicians
16.
go back to reference Jenkins PA: The laboratory diagnosis of mycobacterial disease. Commun Dis Rep CDR Rev. 1992, 2: R101-R103.PubMed Jenkins PA: The laboratory diagnosis of mycobacterial disease. Commun Dis Rep CDR Rev. 1992, 2: R101-R103.PubMed
17.
Metadata
Title
Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006
Authors
Jonathan E Moore
Michelle E Kruijshaar
L Peter Ormerod
Francis Drobniewski
Ibrahim Abubakar
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-612

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue